Control of acute severe hypertension with low rate of overshoot4
Low rate of overshoot† in acute severe hypertension patients4
- 1.6% of patients (N=2) experienced overshoot within the first 3 minutes after start of infusion. These 2 patients continued CLEVIPREX infusion beyond 18 hours without experiencing any adverse events4
- In this study, the incidence of adverse events leading to study drug discontinuation was 4.8%1
†Overshoot was defined as SBP below the prespecified initial target range within the first 3 minutes of starting the infusion.